Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School

Generated: November 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017453

« Back to Dashboard

NDA 017453 describes PROGLYCEM, which is a drug marketed by Teva Branded Pharm and is included in two NDAs. It is available from one supplier. Additional details are available on the PROGLYCEM profile page.

The generic ingredient in PROGLYCEM is diazoxide. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diazoxide profile page.
Summary for 017453
Applicant:Teva Branded Pharm
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017453
Suppliers and Packaging for NDA: 017453
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROGLYCEM diazoxide SUSPENSION;ORAL 017453 NDA Teva Pharmaceuticals USA, Inc. 0575-6200 0575-6200-30 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) > 30 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength50MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Farmers Insurance
Argus Health
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.